Trademark Overview
On Thursday, February 6, 2025, a trademark application was filed for ALCO5 with the United States Patent and Trademark Office. The USPTO has given the ALCO5 trademark a serial number of 79418920. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Tuesday, February 24, 2026. This trademark is owned by Tubulis GmbH. The ALCO5 trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:
Scientific and technological services, namely scientific research, analysis, testing and design in the fields of biology, chemistry or medicine, as well as in the fields of immunology, oncology, molecular biology, cellular biology, biochemistry and medicinal chemistry as well as in the fields of discovery and development of pharmaceuticals, medical and veterinary preparations, diagnostic preparations, biomarker reagents and diagnostic apparatus
Chemical, biochemical, biological, and biotechnological preparations, in particular, antibodies, fragments of antibodies and antibody-drug conjugates for industrial and scientific use; antibodies, fragments of antibodies and antibody-drug conjugates for the development or manufacture of therapeutic reagents for industrial and scientific use; biological preparations, in particular, antibodies, fragments of antibodies and antibody-drug conjugates for laboratories, diagnostics and analytics for scientific or research use; chemical, biochemical, biological, and biotechnological preparations for industrial and scientific use.
Pharmaceutical and veterinary preparations and substances for the treatment of cancer, inflammatory diseases, autoimmune diseases, infective diseases, cardiovascular diseases, liver metabolic disorders and other conditions which can be treated or ameliorated by antibodies binding to, or activation or blocking of, a target antigen; therapeutic pharmaceuticals, namely antibody-drug conjugates for the treatment of cancer and autoimmune diseases; pharmaceutical and veterinary preparations for the treatment of cancer, inflammatory diseases, autoimmune diseases, infective diseases, cardiovascular diseases and liver metabolic disorders comprising small molecules; small molecule compounds being pharmaceuticals for the treatment of cancer